Release Date: 12/08/13 08:28 Summary: Texas Asset Sale Finalised and Appendix 3B Price Sensitive: No Download Document 508.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%